Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) The first report of 10-year outcomes of hepatocellular carcinoma treated by percutaneous radio frequency ablation (RFA) indicates that about 1 in 4 patients survive…
NEW YORK (Reuters Health) – For women with breast cancer metastatic to bone, treatment with zoledronic acid to reduce skeletal complications does not prolong progression-free survival or overall…
NEW YORK (Reuters Health) – A large multicenter study confirms that placement of self-expanding metal stents in the colon in cases of malignant colorectal obstruction restores bowel transit…
NEW YORK (Reuters Health) – In recurrent ovarian cancer, combination docetaxel and carboplatin may provide an advantage in terms of progression-free survival (PFS) over sequential docetaxel-carboplatin, according to…
NEW YORK (Reuters Health) – Among patients with early stage non-small-cell lung cancer, treatment with gemcitabine and cisplatin before radical surgery is associated with better survival than is…
NEW YORK (Reuters Health) – Acupuncture given simultaneously with radiotherapy to the head and neck reduces the development and severity of xerostomia (dry mouth) and improves quality of…
NEW YORK (Reuters Health) – When colorectal metastases to the liver are resectable, preoperative chemo is not beneficial. For unresectable lesions, however, chemotherapy to downsize the lesions can…
NEW YORK (Reuters Health) – In selected patients, colectomy can be performed laparoscopically via a single port. However, the advantages of this technique over multiport laparoscopic colectomy seem…
NEW YORK (Reuters Health) – Treatment with the angiotensin receptor blocker (ARB) candesartan is not associated with either carcinogenesis or cancer death compared with non-ARB standard antihypertensive treatment,…
NEW YORK (Reuters Health) – Bone loss in postmenopausal women taking adjuvant letrozole for early breast cancer can be prevented with administration of zoledronic acid, investigators report in…
